PHARMACEUTICAL ATTENTION TO THE TREATMENT OF ONCOLOGICAL PATIENTS: A SYSTEMATIC REVIEW

Abstract

Cancer is one of the main public health problems worldwide and its therapy has  become highly specialized and well advanced in recent years. Objective: This study aims to  analyze the impact of pharmaceutical interventions in the treatment of cancer patients, focusing  on aspects related to the dimensions of guidance and pharmaceutical care. Materials and  Methods: This review included articles published in the Virtual Health Library (BVS), SCIELO  and PubMed databases. Publications in Portuguese and English, from 2012 to 2022 were  considered. The Boolean operator “and” and Descriptors in Health Sciences (DeCS) in English  and Portuguese were used, these being “Pharmaceutical Care” and “Oncology” and “Clinical  Pharmacist” and “Cancer”. Systematic review and literature review articles were excluded.  Results: 12 articles were selected for this systematic review. The studies analyzed in their  conclusions prove the need for the insertion of the pharmaceutical professional in the cancer  care team. Conclusion: The participation of the pharmacist in the oncology care team is efficient and provides the optimization of the pharmacotherapeutic treatment of patients, increasing  adherence to treatment, reducing drug-related problems (DRPs) and helping to improve the  quality of life.